0000950123-22-009431.txt : 20220815
0000950123-22-009431.hdr.sgml : 20220815
20220815160241
ACCESSION NUMBER: 0000950123-22-009431
CONFORMED SUBMISSION TYPE: 13F-NT
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220815
DATE AS OF CHANGE: 20220815
EFFECTIVENESS DATE: 20220815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BC SW, LP
CENTRAL INDEX KEY: 0001786351
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-NT
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20270
FILM NUMBER: 221165593
BUSINESS ADDRESS:
STREET 1: 200 CLAREDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162000
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-NT
1
primary_doc.xml
13F-NT
LIVE
0001786351
XXXXXXXX
06-30-2022
06-30-2022
false
BC SW, LP
200 Clarendon Street
Boston
MA
02116
13F NOTICE
028-20270
28-18477
Bain Capital Life Sciences Investors, LLC
Y
The report on Form 13F for the period ended June 30, 2022 for BC SW, LP ("BC SW") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of BC SW.
Adam Koppel
Managing Dir. of Bain Capital Life Sciences Investors, LLC
617-516-2000
/s/ Adam Koppel
Boston
MA
08-15-2022